From measurement to outcomes in longevity

Weekly Longevity Newsletter | 17 August 2026

This week, three independent developments published in longevity research pointed in the same direction:

The importance of a measurement depends less on how sophisticated the technology behind it is than on how accurately it reflects a person’s actual health.

Can one biological age describe the entire body?

In a new study published in Nature Medicine, artificial intelligence was used to examine more than 25,000 histological images from 40 different tissues obtained from 983 people.

The researchers developed separate “tissue ages” assessing the structural integrity of tissues and the microscopic changes that occur with ageing. The findings showed that ageing does not progress at the same pace in every organ. In some people it affected many tissues together, while in others a particular organ, such as the heart, lungs or stomach, could age more rapidly.

This study strengthens an important possibility:

In the future, rather than relying on a single “biological age”, we may assess the pace of ageing of different organs and tissues separately.

There is, however, an important limitation. This research does not directly validate commercial tests currently marketed as your “heart age”, “brain age” or “organ age”. The models developed are research tools and rely largely on tissue images.

For now, the conclusion is therefore not that a new organ-age test is ready for clinical use, but that a single score may be insufficient to represent ageing across the entire body.

What we can do matters as much as our list of diseases

A second study published in JAMA Network Open moved the discussion from the laboratory to everyday life.

Researchers followed 13,423 people aged 65 and over for a median of seven years. Beyond recording their diseases or self-reported physical activity, they objectively measured:

  • balance and mobility,

  • lower- and upper-body strength,

  • cardiorespiratory capacity,

  • flexibility

using standardised tests.

People with better balance and agility, lower-limb strength and cardiorespiratory capacity had a markedly lower risk of death from any cause. A composite assessment combining several performance measurements showed a stronger association than individual tests.

This was an observational study. It therefore does not prove that good balance or strong legs alone extend life. Reverse causation and other unmeasured factors cannot be completely ruled out.

Nevertheless, the study highlights an important clinical point:

We cannot understand a person’s health simply by looking at which diseases they have. Their strength, balance, endurance and mobility also provide distinct prognostic information.

Why does XPRIZE look beyond ageing clocks?

The third development of the week came from the $101 million XPRIZE Healthspan competition.

Twenty finalists were announced who will advance to the clinical-trial stage. Ten of them received $1 million each to accelerate their work.

The aim is not simply to change a biomarker or turn an epigenetic clock back by a few years. Teams are expected to demonstrate measurable, meaningful improvements within one year in people aged 50–90 in:

  • muscle function,

  • cognitive performance,

  • immune function.

In other words, the competition’s fundamental question is not “Did the test result become younger?”

Did the person genuinely become stronger, clearer in their thinking, more resilient and more independent?

My takeaway this week

Longevity has long focused on measuring biomarkers, biological ages and various scores. These measurements are not without value. Used appropriately, they can help us identify risk earlier, plan personalised interventions and monitor change.

But the clinical value of a measurement does not come simply from appearing technologically advanced.

The real questions are:

Which decision did this measurement change?

Did the person’s health risk decrease after the intervention?

Six months later, are they stronger, more resilient, more mobile and in better cognitive shape?

I believe the future of longevity will be built less on producing more scores and more on showing whether health, function and performance genuinely improve over time.

The same issue arises when assessing obesity

This approach does not apply only to biological age.

Another new study published in JAMA Network Open found important differences in organ involvement, disease burden, cardiovascular risk and surgical risk among candidates for bariatric surgery with similar BMI distributions.

BMI gives us information about body size, but on its own it does not show fat distribution, damage to organs or a person’s everyday functioning.

Obesity therefore needs to be assessed not only through weight or BMI, but alongside body composition, metabolic effects, organ function and physical capacity.

Wishing you a healthy and strong week.

Dr. Halil Ertürk
Internal Medicine Specialist

This newsletter is for general information and does not replace individual medical assessment or treatment advice.